Skip to main content
BrainCited

Curcumin untuk Age-Related Cognitive Decline

B Bukti Setidaknya satu uji coba acak mendukung hal ini, dengan hasil yang sebagian besar konsisten.

A UCLA 18-month RCT found bioavailable curcumin improved memory test performance and reduced brain amyloid/tau PET signals in non-demented adults. Bioavailability of the formulation is the key factor for effectiveness.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Kesimpulan

A UCLA 18-month RCT found bioavailable curcumin improved memory test performance and reduced brain amyloid/tau PET signals in non-demented adults. Bioavailability of the formulation is the key factor for effectiveness.

Key Study Findings

Review
Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging.
Dose: None vs: None Outcome: None Efek: None None

Populasi: aging individuals with cognitive decline

Review
Brain Neurotrophins and Plant Polyphenols: A Powerful Connection.
Dose: None vs: None Outcome: None Efek: None None

Populasi: None

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs: None Outcome: Cognitive decline in AD Efek: None None

Populasi: Alzheimer's disease patients

Review
Plant-based strategies against aging: Focus on bioactive compounds from medicine-food homology plants.
Dose: None vs: None Outcome: None Efek: None None

Populasi: None

Key Statistics

10

Studi

800

Peserta

Mixed

B

Peringkat

Referenced Papers

Molecules (Basel, Switzerland) 2025 16 sitasi
Roczniki Panstwowego Zakladu … 2021 45 sitasi
Molecules (Basel, Switzerland) 2020 36 sitasi
International journal of … 2018 126 sitasi
Acta bio-medica : … 2018 103 sitasi
Molecular neurobiology 2010 145 sitasi
The Proceedings of … 2002 191 sitasi

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

general:
500-2,000 mg/day of enhanced bioavailability form
cognitivesupport:
90-180 mg/day Theracurmin or equivalent

Batas atas: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term

Dosis yang Diteliti dalam Penelitian

Dosis Durasi Efek N
None -- Positive --
None -- Mixed --
None -- Mixed --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
None -- Mixed --
None -- Positive --
100 mg/kg each 4 weeks Positive --

Waktu terbaik diminum: With meals containing fat and black pepper (piperine) for absorption

Safety & Side Effects

Efek Samping yang Dilaporkan

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Skin rash (rare)
  • Yellow staining of teeth with powder forms

Interaksi yang Diketahui

  • Anticoagulants (may increase bleeding risk)
  • Antidiabetic drugs (may enhance blood sugar lowering)
  • CYP450 substrates (may affect drug metabolism)
  • Iron supplements (curcumin may chelate iron)

Asupan atas yang dapat ditoleransi: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Curcumin help with Age-Related Cognitive Decline?
Based on 10 studies with 800 participants, there is moderate evidence from clinical studies that Curcumin may support Age-Related Cognitive Decline management. Our evidence grade is B (Good Evidence).
How much Curcumin should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 500-2,000 mg/day of enhanced bioavailability form. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Skin rash (rare), Yellow staining of teeth with powder forms. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Age-Related Cognitive Decline?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 800 total participants. The overall direction of effect is mixed.

References

  1. [1] Falguni Goel et al.. 3 Biotech. 2026. Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging. doi:10.1007/s13205-025-04673-z PubMed
  2. [2] Marco Fiore et al.. Molecules. 2025. Brain Neurotrophins and Plant Polyphenols: A Powerful Connection. doi:10.3390/molecules30122657 PubMed
  3. [3] Büşra Yurt Turer et al.. Nutr Rev. 2025. Relationship of Curcumin with Aging and Alzheimer and Parkinson Disease, the Most Prevalent Age-Related Neurodegenerative Diseases: A Narrative Review. doi:10.1093/nutrit/nuae079 PubMed
  4. [4] Mahsa Yavari et al.. Nutrients. 2025. Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids. doi:10.3390/nu17071203 PubMed
  5. [5] Paola Gualtieri et al.. Nutrients. 2025. Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease. doi:10.3390/nu17050922 PubMed
  6. [6] Yun-Fei Zhu et al.. Phytomedicine. 2025. Plant-based strategies against aging: Focus on bioactive compounds from medicine-food homology plants. doi:10.1016/j.phymed.2025.157052 PubMed
  7. [7] Samuel Abiodun Kehinde et al.. Int J Mol Sci. 2025. Curcumin and Dementia: A Systematic Review of Its Effects on Oxidative Stress and Cognitive Outcomes in Animal Models. doi:10.3390/ijms26147026 PubMed
  8. [8] Nida Rasheed et al.. Exp Gerontol. 2025. Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease in aged … doi:10.1016/j.exger.2024.112659 PubMed
  9. [9] Hao Jiao et al.. Front Aging Neurosci. 2025. Curcumin and neuroplasticity: epigenetic mechanisms underlying cognitive enhancement in aging and neurodegenerative disorders. doi:10.3389/fnagi.2025.1592280 PubMed
  10. [10] Wenhui Liu et al.. Ecotoxicol Environ Saf. 2025. Mitochondrial translation impairment-triggered neuroinflammation mediates fluoride-induced cognitive deficits. doi:10.1016/j.ecoenv.2025.119187 PubMed
  11. [11] Feng Gu et al.. Asia Pac J Clin Nutr. 2025. Effects of plant-derived dietary antioxidants on Alzheimer's disease: Focus on ferroptosis. doi:10.6133/apjcn.202512_34(6).0007 PubMed
  12. [12] Bridget Martinez et al.. Neural Regen Res. 2025. Amelioration of behavioral and neural deficits in animal models of neurodegenerative disease by nanoformulations of curcumin and quercetin. doi:10.4103/NRR.NRR-D-25-00343 PubMed
  13. [13] Long Chen et al.. Phytother Res. 2025. Natural Products and Exercise Synergy: Unraveling Molecular Mechanisms to Enhance Brain Function in Alzheimer's Disease. doi:10.1002/ptr.70005 PubMed
  14. [14] Xueyan Feng et al.. Front Pharmacol. 2025. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of … doi:10.3389/fphar.2025.1672171 PubMed
  15. [15] Xiaopeng Li et al.. Neurochem Res. 2025. Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic Potential. doi:10.1007/s11064-025-04623-4 PubMed
  16. [16] Bruno S Goncalves et al.. Front Nutr. 2025. Nutritional strategies against dementia in rural populations. doi:10.3389/fnut.2025.1677197 PubMed
  17. [17] Jemema Agnes Tripena Raj et al.. Brain Res. 2025. RAGE signaling pathway in glioblastoma and cognitive decline: Insights into inflammatory mechanisms and therapeutic implications. doi:10.1016/j.brainres.2025.150026 PubMed
  18. [18] Yanxia Lu et al.. Nutrients. 2025. Curcumin-Rich Curry Consumption Is Associated with Lower Risk of Cognitive Decline and Incidence of Mild Cognitive Impairment or Dementia: An … doi:10.3390/nu17152488 PubMed
  19. [19] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
  20. [20] JinJin Pei et al.. Ageing Res Rev. 2024. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review. doi:10.1016/j.arr.2024.102393 PubMed
  21. [21] Yoonsu Kim et al.. Biomed Pharmacother. 2024. Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut-brain axis. doi:10.1016/j.biopha.2024.117277 PubMed
  22. [22] Faizan Ahmad et al.. Ageing Res Rev. 2024. Evolving therapeutic interventions for the management and treatment of Alzheimer's disease. doi:10.1016/j.arr.2024.102229 PubMed
  23. [23] Priscila Baltazar Gonçalves et al.. Eur J Med Chem. 2024. Natural products targeting amyloid-β oligomer neurotoxicity in Alzheimer's disease. doi:10.1016/j.ejmech.2024.116684 PubMed
  24. [24] Bianca Sânziana Daraban et al.. Molecules. 2024. Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems. doi:10.3390/molecules29174056 PubMed
  25. [25] Meysam Amidfar et al.. CNS Neurol Disord Drug Targets. 2024. Role of BDNF Signaling in the Neuroprotective and Memory-enhancing Effects of Flavonoids in Alzheimer's Disease. doi:10.2174/1871527323666230912090856 PubMed
  26. [26] Oana M Dumitrascu et al.. Acta Neuropathol Commun. 2024. Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial. doi:10.1186/s40478-024-01810-2 PubMed
  27. [27] Longmin Fan et al.. Naunyn Schmiedebergs Arch Pharmacol. 2024. Therapeutic potential of curcumin on the cognitive decline in animal models of Alzheimer's disease: a systematic review and meta-analysis. doi:10.1007/s00210-024-02946-7 PubMed
  28. [28] Erjola Bej et al.. Cells. 2024. Neuronal Cell Rearrangement During Aging: Antioxidant Compounds as a Potential Therapeutic Approach. doi:10.3390/cells13231945 PubMed
  29. [29] Davide Decandia et al.. Int J Mol Sci. 2023. Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer's Disease Animal Models of Lipopolysaccharide-Induced Inflammation. doi:10.3390/ijms24065921 PubMed
  30. [30] Emily Knight et al.. Metabolites. 2023. The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer's Disease Treatment. doi:10.3390/metabo13030438 PubMed
  31. [31] Giuseppe Caruso et al.. Pharmacol Ther. 2022. Polyphenols and neuroprotection: Therapeutic implications for cognitive decline. doi:10.1016/j.pharmthera.2021.108013 PubMed
  32. [32] Haya Hussain et al.. Molecules. 2022. Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs. doi:10.3390/molecules27082468 PubMed
  33. [33] Aldo Efrain González-Granillo et al.. J Chem Neuroanat. 2022. Curcumin induces cortico-hippocampal neuronal reshaping and memory improvements in aged mice. doi:10.1016/j.jchemneu.2022.102091 PubMed
  34. [34] Massimiliano Cuccioloni et al.. Int J Mol Sci. 2022. Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization. doi:10.3390/ijms23158710 PubMed
  35. [35] Ajay Uprety et al.. Behav Neurosci. 2022. Curcumin improves reversal learning in middle-aged rhesus monkeys. doi:10.1037/bne0000497 PubMed
  36. [36] Friedrich Leblhuber et al.. Nutrients. 2021. The Immunopathogenesis of Alzheimer's Disease Is Related to the Composition of Gut Microbiota. doi:10.3390/nu13020361 PubMed
  37. [37] Sylwia Śliwińska et al.. Rocz Panstw Zakl Hig. 2021. The role of nutrition in Alzheimer's disease. doi:10.32394/rpzh.2021.0154 PubMed
  38. [38] W Yang et al.. J Nutr Health Aging. 2021. Effect of Polyphenols on Cognitive Function: Evidence from Population-Based Studies and Clinical Trials. doi:10.1007/s12603-021-1685-4 PubMed
  39. [39] I-Chen Tsai et al.. Pharmaceuticals (Basel). 2021. The Effect of Curcumin Differs on Individual Cognitive Domains across Different Patient Populations: A Systematic Review and Meta-Analysis. doi:10.3390/ph14121235 PubMed
  40. [40] Oana M Dumitrascu et al.. Cells. 2021. Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study. doi:10.3390/cells10112926 PubMed
  41. [41] Alessandra Berry et al.. Nutrients. 2021. Curcuma Longa, the "Golden Spice" to Counteract Neuroinflammaging and Cognitive Decline-What Have We Learned and What Needs to Be Done. doi:10.3390/nu13051519 PubMed
  42. [42] Umair Shabbir et al.. Int J Mol Sci. 2020. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology. doi:10.3390/ijms22010196 PubMed
  43. [43] Guangchi Sun et al.. Brain Res Bull. 2020. Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury. doi:10.1016/j.brainresbull.2020.05.009 PubMed
  44. [44] Mahitab Farghali et al.. Brain Sci. 2020. Can Brain Health Be Supported by Vitamin D-Based Supplements? A Critical Review. doi:10.3390/brainsci10090660 PubMed
  45. [45] Stella Gagliardi et al.. Molecules. 2020. Curcumin Formulations and Trials: What's New in Neurological Diseases. doi:10.3390/molecules25225389 PubMed
  46. [46] Julia C Kuszewski et al.. J Nutr. 2020. Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity. doi:10.1093/jn/nxaa299 PubMed
  47. [47] Li-Na Zhu et al.. Phytother Res. 2019. Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis. doi:10.1002/ptr.6257 PubMed
  48. [48] P Hemachandra Reddy et al.. J Alzheimers Dis. 2018. Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease. doi:10.3233/JAD-170512 PubMed
  49. [49] Callum Ross et al.. Int J Nanomedicine. 2018. Liposome delivery systems for the treatment of Alzheimer's disease. doi:10.2147/IJN.S183117 PubMed
  50. [50] Ligia J Dominguez et al.. Acta Biomed. 2018. Nutritional prevention of cognitive decline and dementia. doi:10.23750/abm.v89i2.7401 PubMed
  51. [51] Marjana Rahman Sarker et al.. Geroscience. 2018. Efficacy of curcumin for age-associated cognitive decline: a narrative review of preclinical and clinical studies. doi:10.1007/s11357-018-0017-z PubMed
  52. [52] Arrigo F G Cicero et al.. Pharmacol Res. 2018. Botanicals and phytochemicals active on cognitive decline: The clinical evidence. doi:10.1016/j.phrs.2017.12.029 PubMed
  53. [53] Julia Christina Kuszewski et al.. Adv Nutr. 2018. Can Curcumin Counteract Cognitive Decline? Clinical Trial Evidence and Rationale for Combining ω-3 Fatty Acids with Curcumin. doi:10.1093/advances/nmx013 PubMed
  54. [54] Shibu M Poulose et al.. Adv Nutr. 2017. Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function. doi:10.3945/an.117.016261 PubMed
  55. [55] Melania Maria Serafini et al.. Pharmacol Res. 2017. Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule? doi:10.1016/j.phrs.2017.08.004 PubMed
  56. [56] Fu-Chun Zhao et al.. Med Sci Monit. 2017. Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia. doi:10.12659/msm.901842 PubMed
  57. [57] Graziamaria Corbi et al.. Front Pharmacol. 2016. Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans? doi:10.3389/fphar.2016.00364 PubMed
  58. [58] Jessica E Beilharz et al.. Nutrients. 2015. Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional Interventions. doi:10.3390/nu7085307 PubMed
  59. [59] Christopher Millington et al.. Biomed Res Int. 2014. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs. doi:10.1155/2014/309129 PubMed
  60. [60] William O Ogle et al.. Gerontology. 2013. Potential of treating age-related depression and cognitive decline with nutraceutical approaches: a mini-review. doi:10.1159/000342208 PubMed
  61. [61] Sally A Frautschy et al.. Mol Neurobiol. 2010. Why pleiotropic interventions are needed for Alzheimer's disease. doi:10.1007/s12035-010-8137-1 PubMed
  62. [62] Michael Grundman et al.. Proc Nutr Soc. 2002. Antioxidant strategies for Alzheimer's disease. doi:10.1079/PNS2002146 PubMed

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.